The Association between Cerebral Oxygenation and CKD in Older Adults

Caoimhe McGarvey1,2, Robert Briggs1,2, Louise Newman1

  • 1The Irish Longitudinal Study on Ageing (TILDA), School of Medicine, Trinity College Dublin, Dublin, Ireland.

Kidney360
|January 15, 2026
PubMed

Insights

Chronic kidney disease (CKD) is linked to lower cerebral oxygenation during standing tests. This finding may explain how CKD contributes to cognitive decline and cerebrovascular disease.

Area of Science:

  • Nephrology
  • Neurology
  • Gerontology

Background:

  • Chronic kidney disease (CKD) is a growing global health concern.
  • CKD is increasingly linked to cerebrovascular disease and cognitive impairment.
  • Understanding the mechanisms connecting CKD to brain health is crucial.

Purpose of the Study:

  • To investigate the relationship between CKD and dynamic changes in cerebral oxygenation.
  • To explore how CKD affects brain blood flow regulation during postural changes.
  • To identify potential mechanisms linking CKD to cognitive decline.

Main Methods:

  • Observational study using data from The Irish Longitudinal Study on Ageing (TILDA).
  • Included 2,322 community-dwelling adults aged ≥50 years.
  • Measured cerebral oxygenation (Tissue Saturation Index) using near-infrared spectroscopy during orthostatic maneuvers; CKD defined by estimated glomerular filtration rate (eGFR).

Main Results:

  • Participants with CKD showed significantly lower cerebral oxygenation post-standing compared to those without CKD.
  • Lower eGFR was independently associated with reduced cerebral oxygenation.
  • Orthostatic hypotension amplified the association, while systolic hypotension may mitigate it.

Conclusions:

  • CKD is independently associated with reduced cerebral oxygenation during orthostatic challenge.
  • This reduced oxygenation may be a key mechanism linking CKD to cognitive impairment.
  • Cerebral oxygenation could serve as a predictive biomarker for cognitive decline in CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
565
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
555
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
237
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
899
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
260